Skip to main content
Fig. 3 | Cancer Nanotechnology

Fig. 3

From: Hypobaric hypoxia exposure regulates tissue distribution of nanomedicine for enhanced cancer therapy

Fig. 3

Tissue distribution of PTX-LPs in the heart, liver, spleen, lung, kidney, brain, large intestine, small intestine, stomach, and subcutaneous tumor after HH and HBO exposure. Subcutaneous tumor-bearing BALB/c mice were intravenously injected with PTX-LPs (5 mg PTX/kg body weight) and immediately subjected to HH or HBO exposure for 1.5 h. Data were presented as mean ± SEM (n = 4). *p < 0.05 and **p < 0.01

Back to article page